Sickle Cell Scholar

镰状细胞学者

• 批准号: 7828051
• 负责人: Martin H. Steinberg
• 金额: $ 18.65万
• 依托单位: BOSTON MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-04 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7828051
• 关键词: Agreement; Americas; Award; Boston; Clinical; Communities; Community Physician; Consultations; Data; Data Set; Databases; Ensure; Family; Functional disorder; Funding; Gene Family; Genes; Genetic; Genotype; Goals; Grant; Guidelines; Home environment; Individual; Institution; Joints; Journals; Letters; Link; Medical; Medical center; Mentors; Morbidity - disease rate; National Heart, Lung, and Blood Institute; Patients; Peer Review; Policies; Policy Research; Psychology; Publications; Publishing; Qualifying; Reporting; Research; Research Infrastructure; Research Personnel; Resources; Sampling; Scientist; Sickle Cell; Sickle Cell Anemia; Site; Software Tools; Supervision; Support Groups; Testing; Text; Textbooks; Time; Work; career; data sharing; dissemination research; experience; genetic analysis; genome-wide; interest; lectures; meetings; member; mortality; programs; success; web site

We plan for the next Sickle Cell Scholar to provide protected time and the resources necessary for a young investigator or investigator new to the field to pursue original research relevant to understanding the genetics, pathophysiology, psychology or treatment of sickle cell disease. To facilitate this we will provide an experienced mentor capable of guiding this work to a successful conclusion, encourage productive interactions between the Scholar, other members of the Boston Comprehensive Sickle Cell Center (BCSCC) and sickle cell disease investigators throughout the nation and provide an infrastructure to allow the Sickle Cell Scholar ultimately to pursue a career of peer-reviewed independent research

我们计划为下一个镰状细胞学者提供保护的时间和必要的资源，为年轻的 研究者或新进入该领域的研究者进行与了解 遗传学、病理生理学、心理学或镰状细胞病的治疗。为了实现这一点，我们将提供一个 有经验的导师能够指导这项工作取得圆满成功，鼓励富有成效的 学者，波士顿综合镰状细胞中心（BCSCC）的其他成员之间的互动 和镰状细胞病调查人员在全国各地，并提供一个基础设施，使镰状细胞病 Cell Scholar最终将从事同行评审的独立研究